MODD vs. BSGM, PDEX, LNSR, LAKE, AVR, PROF, ZJYL, LUCD, RCEL, and OBIO
Should you be buying Modular Medical stock or one of its competitors? The main competitors of Modular Medical include Biosig Technologies (BSGM), Pro-Dex (PDEX), LENSAR (LNSR), Lakeland Industries (LAKE), Anteris Technologies Global (AVR), Profound Medical (PROF), Jin Medical International (ZJYL), Lucid Diagnostics (LUCD), Avita Medical (RCEL), and Orchestra BioMed (OBIO). These companies are all part of the "medical equipment" industry.
Modular Medical vs. Its Competitors
Modular Medical (NASDAQ:MODD) and Biosig Technologies (NASDAQ:BSGM) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, institutional ownership, media sentiment, analyst recommendations, earnings, profitability, dividends and valuation.
Biosig Technologies has higher revenue and earnings than Modular Medical.
Modular Medical has a beta of 0.17, indicating that its share price is 83% less volatile than the S&P 500. Comparatively, Biosig Technologies has a beta of 1.82, indicating that its share price is 82% more volatile than the S&P 500.
27.5% of Modular Medical shares are owned by institutional investors. Comparatively, 7.2% of Biosig Technologies shares are owned by institutional investors. 20.5% of Modular Medical shares are owned by company insiders. Comparatively, 24.8% of Biosig Technologies shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
In the previous week, Biosig Technologies had 3 more articles in the media than Modular Medical. MarketBeat recorded 3 mentions for Biosig Technologies and 0 mentions for Modular Medical. Modular Medical's average media sentiment score of 0.36 beat Biosig Technologies' score of 0.00 indicating that Modular Medical is being referred to more favorably in the media.
Modular Medical's return on equity of -185.60% beat Biosig Technologies' return on equity.
Biosig Technologies has a consensus target price of $10.00, suggesting a potential upside of 112.31%. Given Biosig Technologies' stronger consensus rating and higher possible upside, analysts clearly believe Biosig Technologies is more favorable than Modular Medical.
Summary
Biosig Technologies beats Modular Medical on 9 of the 12 factors compared between the two stocks.
Get Modular Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for MODD and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding MODD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Modular Medical Competitors List
Related Companies and Tools
This page (NASDAQ:MODD) was last updated on 9/4/2025 by MarketBeat.com Staff
